Incidence and management of myelosuppression in patients with chronic-and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate

Luke Akard, Hagop M. Kantarjian, Franck E. Nicolini, Meir Wetzler, Jeffrey H. Lipton, Michele Baccarani, H. Jean Khoury, Sandra Kurtin, Elizabeth Li, Mihaela Munteanu, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Incidence and management of myelosuppression in patients with chronic-and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate'. Together they form a unique fingerprint.

Medicine & Life Sciences